R

Regeneron Pharmaceuticals

Develops biopharmaceutical therapies for serious diseases

Executive Director - Commercial Insights & Analytics, Ophthalmology

Corporate StrategyConfirmed live in the last 24 hours
Full-time$255k - $424.9k /yr

About the Job

Requirements

  • At least 20 years of pharmaceutical or biotechnology commercial experience in roles of increasing accountability; prior experience with buy-and-bill brands in highly competitive markets is required.
  • A minimum Bachelor's degree in data science, public health, statistics, engineering, or a related field is required.
  • Functional expertise in business analytics, customer insights, analog forecast development, market access, and competitive intelligence.
  • Prior experience managing I&A groups responsible for analytics, customer insights, market access analytics, and competitive intelligence.
  • Demonstrated knowledge of the legal and regulatory environment as it relates to commercialization in the pharmaceutical or biotechnology industry.
  • Knowledge of data industry standards.
  • Ability to influence, communicate, and negotiate with management across functional and business unit boundaries.
  • Extensive experience managing numerous projects concurrently against stringent deadlines.
  • Prior experience with I&A projects and initiatives requiring a balance between project rigor and timeliness.
  • Ability to take strategy through execution, with hands-on experience implementing large initiatives with cross-functional stakeholders.
  • Expertise in data visualization and data storytelling.
  • Strong interpersonal, facilitation, and communication skills, including the ability to resolve conflict, drive consensus, and work across multiple departments.
  • Strong organizational, project management, influencing, and change management skills.
  • Ability to manage multiple projects and priorities concurrently while meeting stringent deadlines.

Responsibilities

  • Lead and mentor the CSI&A Ophthalmology team in providing business analytics, customer insights, and competitive intelligence to solve key business problems.
  • Set the strategic I&A direction to align with CBU priorities and drive launch excellence.
  • Serve as a member of the Ophthalmology CBU Leadership Team, providing I&A expertise.
  • Serve as a member of the CSI&A leadership team to drive cross-commercial innovation and best-in-class delivery.
  • Translate complex analyses into insights and recommendations that inform business decisions for senior Regeneron teams, including the CBU, Chief Commercial Officer, Chief Executive Officer, and Board of Directors.
  • Develop people in functional skills and leadership, with the goal of growing internal talent.
  • Assess and implement methodologies and frameworks to generate insights that inform brand differentiation, market growth, and business impact, and to consider business potential for pipeline products.
  • Collaborate with the Ophthalmology CBU and senior leaders on brand strategies and decisions, including the long-term data, analytics, and insights roadmap.
  • Develop and maintain partnerships with CBU stakeholders, ensure insight generation and feedback are embraced, and balance project rigor, timelines, and influence on decisions.
  • Lead efforts to identify and crystallize insights that inform strategic plans for the Ophthalmology CBU.
  • Work with other CSI&A leads to develop standardized adoption of marketing mix, promotional optimization, data science, market structure analyses, patient and treatment flow modeling, analog modeling, and machine learning/artificial intelligence methodologies across I&A.
  • Proactively communicate strategic recommendations, insights, and anticipated future needs to the Ophthalmology CBU.
  • Construct and deliver integrated business reviews and I&A summary overviews with the Ophthalmology CBU and CSI&A leadership.
  • Manage third-party vendor relationships.

Desired Qualifications

  • Ophthalmology disease category experience is strongly desired.
  • MBA, MPH, or MS degree is preferred.

About the Company

Regeneron Pharmaceuticals

Develops biopharmaceutical therapies for serious diseases

Regeneron Pharmaceuticals develops and commercializes medicines for serious diseases, with a focus on cancer, eye diseases, allergic and inflammatory diseases, and infectious diseases. Its products come from using proprietary research capabilities and technologies to discover and develop therapies, often in collaboration with academic, research, and industry partners. Revenue comes from selling approved medicines and from licensing its technologies and entering co-development and co-commercialization partnerships. The company works with healthcare providers and regulators to ensure treatment delivery and safety. Its goal is to improve patient outcomes by bringing life-transforming medicines to market through rigorous R&D and strategic collaborations, maintaining leadership in biopharmaceutical innovation.

Company size
10,001+
Company stage
IPO
Headquarters
Town of Mount Pleasant, New York
Founded
1988

Recently Posted Jobs

Explore more opportunities at Regeneron Pharmaceuticals

See more jobs